3/4
05:57 am
cccc
C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
Low
Report
C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
2/27
07:08 pm
cccc
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
2/27
07:00 am
cccc
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Low
Report
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
2/24
07:09 am
cccc
C4 Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
C4 Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/24
07:00 am
cccc
C4 Therapeutics to Participate in Upcoming March Investor Conferences
Medium
Report
C4 Therapeutics to Participate in Upcoming March Investor Conferences
2/19
06:31 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at UBS Group AG to a "hold" rating.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at UBS Group AG to a "hold" rating.
1/14
07:38 am
cccc
C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology [Yahoo! Finance]
Medium
Report
C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology [Yahoo! Finance]
1/14
07:00 am
cccc
C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology
Medium
Report
C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology
2/27/2025
07:00 am
CCCC
c4 therapeutics, inc.
MISS
Report
-3.0%
c4 therapeutics, inc.
2/27/2025
07:00 am
CCCC
c4 therapeutics, inc.
MISS
Report
-2.3%
c4 therapeutics, inc.
2/27/2025
07:00 am
CCCC
c4 therapeutics, inc.
MISS
Report
-2.3%
c4 therapeutics, inc.
2/27/2025
07:00 am
CCCC
c4 therapeutics, inc.
MISS
Report
-1.9%
c4 therapeutics, inc.
4/3
04:12 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: Anderson Kenneth Carl
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: Anderson Kenneth Carl
4/3
04:12 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: GROGAN DONNA ROY
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: GROGAN DONNA ROY
2/27
07:20 am
cccc
Form S-8 C4 Therapeutics, Inc.
Low
Report
Form S-8 C4 Therapeutics, Inc.
2/27
07:16 am
cccc
Form 10-K C4 Therapeutics, Inc. For: Dec 31
Low
Report
Form 10-K C4 Therapeutics, Inc. For: Dec 31
2/27
07:08 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Feb 27
Low
Report
Form 8-K C4 Therapeutics, Inc. For: Feb 27
2/18
04:55 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N
Neutral
Report
Form 4 C4 Therapeutics, Inc. For: Feb 13 Filed by: Boyle Scott N
2/18
04:55 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Hirsch Andrew
Neutral
Report
Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Hirsch Andrew
2/18
04:55 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Mossler Mark
Neutral
Report
Form 4 C4 Therapeutics, Inc. For: Feb 14 Filed by: Mossler Mark
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register